North America Dermatology OTC Medications Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution)

Name: North America Dermatology OTC Medications Market
SKU: Pharmaceuticals
Rating: 4.9 (11 reviews)

The North America dermatology OTC medications market is expected to grow from US$ 6,289.64 million in 2021 to US$ 8,721.90 million by 2028; it is estimated to grow at a CAGR of 4.8% from 2021 to 2028.

Skin issues such as pigmentation, wrinkles, creases, acne, and burn scars are common among the masses. The costs associated with acne treatment and lost productivity among those receiving acne treatment exceeded US$ 1.2 billion in 2013; more than 5.1 million people, primarily children, and young adults, were seeking medical treatment for acne in the same year. Further, 1 in 10 people develops atopic dermatitis during their lifetime, and the condition affects up to 25% of children and 2–3% of adults. According to the American Academy of Dermatology Association, acne is the most common skin condition in the US, affecting ~50 million Americans annually. Additionally, ~85% of people aged 12–24 experience minor acne problems. In 2021, according to a poll conducted by Dermstore with 2,000 women across the US, young women started using products to reduce the signs of aging much sooner than older women. Acne vulgaris is becoming more prevalent in every country. Dermatology OTC medications are widely used in the treatment of acne. According to the Global Burden of Disease Study 2019, 117.4 million incident cases of acne vulgaris, 231.2 million prevalent cases, and 5 million disability-adjusted life years (DALYs), representing a 48% increase since 1990. Thus, the high prevalence of skin disease supports the dermatology OTC medications market's growth.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America dermatology OTC medications market. The North America dermatology OTC medications market is expected to grow at a good CAGR during the forecast period.

North America Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

North America Dermatology OTC Medications Market Segmentation

The North America dermatology OTC medications market is segmented into product type, route of administration, indication, distribution channel, and country. Based on product type, the market is segmented into tablets and capsules, gels, creams and ointments, and others. The creams and ointments segment dominated the market in 2020; however, the tablets and capsules segment is expected to be the fastest growing during the forecast period. Based on route of administration, the market is segmented into topical and oral. The topical segment dominated the market in 2020; however, the oral segment is expected to be a faster growing segment during the forecast period. Based on indication, the market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment dominated the market in 2020 and is expected to be the fastest growing segment during the forecast period. The dermatitis segment is further classified into atopic dermatitis, contact dermatitis, and others. The acne segment is further segmented into non-inflammatory acne and inflammatory acne. The psoriasis segment is further segmented into plaque psoriasis, guttate psoriasis, and others. The fungal disease is further segmented into athlete's foot, ringworm, fungal nail infections, and others. Moreover, the warts segment is further segmented into common warts, flat warts, and others. Based on distribution channel, the market is segmented into online distribution and offline distribution. The offline distribution segment dominated the market in 2020; however, the online distribution segment is expected to be a faster segment during the forecast period. The offline distribution is further segmented into retail and hospital pharmacies and super and hypermarkets. Based on country, the market is segmented into the US, Canada, and Mexico.

Acella Pharmaceuticals, LLC; Bausch Health Companies Inc.; Bayer AG; Dr. Reddy's Laboratories; Galderma; GlaxoSmithKline plc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; Perrigo Company plc; and Viatris Inc. are among the leading companies in the North America dermatology OTC medications market.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Dermatology OTC Medications Market – By Product Type

1.3.2 North America Dermatology OTC Medications Market – By Route of Administration

1.3.3 North America Dermatology OTC Medications Market – By Indication

1.3.4 North America Dermatology OTC Medications Market – By Distribution Channel

1.3.5 North America Dermatology OTC Medications Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Dermatology OTC Medications Market – Market Landscape

4.1 Overview

4.2 North America PEST Analysis

4.3 Experts Opinion

5. North America Dermatology OTC Medications Market – Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Strong Prevalence of Skin Problems

5.1.2 Growing Income of Middle-class Population

5.2 Market Restraints

5.2.1 Wrong Use of OTC Medications

5.3 Market Opportunities

5.3.1 Growing OTC Market across Several Countries

5.4 Future Trends

5.4.1 Rising Transition from Rx to OTC

5.5 Impact Analysis of Drivers and Restraints

6. Dermatology OTC Medications Market– North America Analysis

6.1 North America Dermatology OTC Medications Market Revenue Forecast and Analysis

7. North America Dermatology OTC Medications Market Analysis – By Product Type

7.1 Overview

7.2 North America Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

7.3 Tablets and Capsules

7.3.1 Overview

7.3.2 Tablets and Capsules Market Revenue and Forecast to 2028 (US$ million)

7.4 Gels

7.4.1 Overview

7.4.2 Gels Market Revenue and Forecast to 2028 (US$ million)

7.5 Creams and Ointments

7.5.1 Overview

7.5.2 Creams and Ointments Market Revenue and Forecast to 2028 (US$ million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ million)

8. North America Dermatology OTC medications Market Analysis – By Route of Administration

8.1 Overview

8.2 North America Dermatology OTC Medications Market Share, by Route of Administration, 2021 and 2028 (%)

8.3 Topical

8.3.1 Overview

8.3.2 Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Oral

8.4.1 Overview

8.4.2 Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9. North America Dermatology OTC Medications Market Analysis – By Indication

9.1 Overview

9.2 North America Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

9.3 Dermatitis

9.3.1 Overview

9.3.2 Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.3 Atopic Dermatitis

9.3.3.1 Overview

9.3.3.2 Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.4 Contact Dermatitis

9.3.4.1 Overview

9.3.4.2 Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.5 Others

9.3.5.1 Overview

9.3.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4 Acne

9.4.1 Overview

9.4.2 Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.3 Non-Inflammatory Acne

9.4.3.1 Overview

9.4.3.2 Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.4 Inflammatory Acne

9.4.4.1 Overview

9.4.4.2 Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5 Psoriasis

9.5.1 Overview

9.5.2 Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.3 Plaque Psoriasis

9.5.3.1 Overview

9.5.3.2 Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.4 Guttate Psoriasis

9.5.4.1 Overview

9.5.4.2 Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.5 Others

9.5.5.1 Overview

9.5.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.6 Skin Bleaching

9.6.1 Overview

9.6.2 Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7 Fungal Disease

9.7.1 Overview

9.7.2 Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.3 Athlete's Foot

9.7.3.1 Overview

9.7.3.2 Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.4 Ringworm

9.7.4.1 Overview

9.7.4.2 Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.5 Fungal Nail Infections

9.7.5.1 Overview

9.7.5.2 Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.6 Others

9.7.6.1 Overview

9.7.6.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8 Warts

9.8.1 Overview

9.8.2 Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.3 Common Warts

9.8.3.1 Overview

9.8.3.2 Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.4 Flat Warts

9.8.4.1 Overview

9.8.4.2 Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.5 Others

9.8.5.1 Overview

9.8.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10. North America Dermatology OTC medications Market Analysis – By Distribution Channel

10.1 Overview

10.2 North America Dermatology OTC Medications Market Share, by Distribution Channel, 2021 and 2028 (%)

10.3 Online Distribution

10.3.1 Overview

10.3.2 Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Offline Distribution

10.4.1 Overview

10.4.2 Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.3 Retail and Hospital Pharmacies

10.4.3.1 Overview

10.4.3.2 Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.4 Super and Hyper Markets

10.4.4.1 Overview

10.4.4.2 Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

11. North America Dermatology OTC Medications Market Revenue and Forecasts to 2028 – Country Analysis

11.1 North America Dermatology OTC Medications Market Revenue and Forecasts To 2028

11.1.1 Overview

11.1.3 North America Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.1.4 US: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.1 Overview

11.1.4.2 US: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.3 US: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.4.4 US: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.4.5 US: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.4.5.1 US: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.4.5.2 US: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.4.5.3 US: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.4.5.4 US: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.4.5.5 US: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.4.6 US: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.4.6.1 US: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.5 Canada: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.1 Overview

11.1.5.2 Canada: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.3 Canada: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.5.4 Canada: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.5.5 Canada: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.5.5.1 Canada: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.5.5.2 Canada: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.5.5.3 Canada: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.5.5.4 Canada: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.5.5.5 Canada: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.5.6 Canada: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.5.6.1 Canada: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.6 Mexico: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.1 Overview

11.1.6.2 Mexico: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.3 Mexico: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.6.4 Mexico: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.6.5 Mexico: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.6.5.1 Mexico: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.6.5.2 Mexico: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.6.5.3 Mexico: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.6.5.4 Mexico: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.6.5.5 Mexico: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.6.6 Mexico: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.6.6.1 Mexico: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

12. Industry Landscape

12.1 Overview

12.2 Inorganic Growth Strategies

12.2.1 Overview

12.3 Organic Growth Strategies

12.3.1 Overview

13. Company Profiles

13.1 Bausch Health Companies Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Perrigo Company plc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Bayer AG

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Viatris Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Johnson and Johnson Services, Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 LEO Pharma A/S

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 GlaxoSmithKline plc.

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Galderma

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Dr. Reddy's Laboratories

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Acella Pharmaceuticals, LLC

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 Glossary of Terms

LIST OF TABLES

Table 1. North America Dermatology OTC Medications Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2. US: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3. US: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4. US: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 5. US: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 6. US: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 7. US: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 8. US: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 9. US: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 10. US: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11. US: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 12. Canada: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 13. Canada: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14. Canada: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 15. Canada: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 16. Canada: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 17. Canada: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 18. Canada: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 19. Canada: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 20. Canada: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 21. Canada: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 22. Mexico: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 23. Mexico: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 24. Mexico: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 25. Mexico: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 26. Mexico: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 27. Mexico: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 28. Mexico: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 29. Mexico: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 30. Mexico: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 31. Mexico: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 32. Recent Inorganic Growth Strategies

Table 33. Recent Organic Growth Strategies

Table 34. Glossary of Terms

LIST OF FIGURES

Figure 1. North America Dermatology OTC Medications Market Segmentation

Figure 2. North America Dermatology OTC Medications Market, By Country

Figure 3. North America Dermatology OTC Medications Market Overview

Figure 4. Creams and Ointments Segment Held the Largest Share of the Market in 2021

Figure 5. The US held the Largest Share of the Market in 2021

Figure 6. North America: PEST Analysis

Figure 7. Experts Opinion

Figure 8. North America Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints

Figure 9. North America Dermatology OTC Medications Market – By Forecast and Analysis

Figure 10. North America Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

Figure 11. North America Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ million)

Figure 12. North America Gels Market Revenue and Forecasts to 2028 (US$ million)

Figure 13. North America Creams and Ointments Market Revenue and Forecasts to 2028 (US$ million)

Figure 14. North America Others Market Revenue and Forecasts to 2028 (US$ million)

Figure 15. North America Dermatology OTC Medications market Share, by Route of Administration, 2021 and 2028 (%)

Figure 16. North America Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17. North America Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18. North America Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

Figure 19. North America Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20. North America Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21. North America Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22. North America Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23. North America Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24. North America Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25. North America Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26. North America Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27. North America Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28. North America Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29. North America Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. North America Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. North America Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. North America Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33. North America Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34. North America Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35. North America Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36. North America Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37. North America Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38. North America Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39. North America Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40. North America Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 41. North America Dermatology OTC Medications market Share, by Distribution Channel, 2021 and 2028 (%)

Figure 42. North America Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 43. North America Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 44. North America Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 45. North America Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 46. North America: Dermatology OTC Medications Market, by Key Country – Revenue (2021) (USD Million)

Figure 47. North America Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

Figure 48. US: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 49. Canada: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Mexico: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America dermatology OTC medications market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America dermatology OTC medications market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the dermatology OTC medications market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a..	May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele..	May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh..	May 2022

Purchase Options

Single User License

$3000

$2400

Site License

$4000

$3200

Enterprise License

$5000